Dynavax Technologies Corporation
Status: Publicly traded
Direct answer
Dynavax Technologies Corporation is publicly traded on NASDAQ under the ticker DVAX.
Dynavax Technologies Corporation is a biopharmaceutical firm specializing in the development and market introduction of innovative vaccines, primarily operating in the United States. The company's lead product is HEPLISAV-B, a vaccine approved for adults 18 years and older in the U.S. and Europe, which offers protection against all identified subtypes of the hepatitis B virus. Additionally, Dynavax produces and...
Can you invest in Dynavax Technologies Corporation?
Yes. Dynavax Technologies Corporation is publicly traded on NASDAQ under the ticker DVAX.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Open research for Dynavax Technologies Corporation
Detailed equity research is provided by MarketSnap.